Going for your yearly multiple sclerosis MRI? Be aware of the new warnings on contrast agents.

(Posted 7/27/2015 FDA)
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm456012.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

Health care professionals should consider limiting GBCA use to clinical circumstances in which the additional information provided by the contrast is necessary.